SEARCH

SEARCH BY CITATION

LITERATURE CITED

  • Abraham MR, Gerstenblith G. 2007. Preconditioning stem cells for cardiovascular disease: an important step forward. Circ Res 100: 447449.
  • Afzal MR, Haider H, Idris NM, Jiang S, Ahmed RP, Ashraf M. 2010. Preconditioning promotes survival and angiomyogenic potential of mesenchymal stem cells in the infarcted heart via NF-kappaB signaling. Antioxid Redox Signal 12: 693702.
  • Caporossi D, Ciafre SA, Pittaluga M, Savini I, Farace MG. 2003. Cellular responses to H(2)O(2) and bleomycin-induced oxidative stress in L6C5 rat myoblasts. Free Radic Biol Med 35: 13551364.
  • Choi EM. 2011. Protective effect of diazoxide against antimycin A-induced mitochondrial dysfunction in osteoblastic MC3T3-E1 cells. Toxicol In Vitro 25: 16031608.
  • Cui X, Wang H, Guo H, Wang C, Ao H, Liu X, Tan YZ. 2010. Transplantation of mesenchymal stem cells preconditioned with diazoxide, a mitochondrial ATP-sensitive potassium channel opener, promotes repair of myocardial infarction in rats. Tohoku J Exp Med 220: 139147.
  • Ding J, Ge D, Guo W, Lu C. 2009. Diazoxide-mediated growth inhibition in human lung cancer cells via downregulation of beta-catenin-mediated cyclin D1 transcription. Lung 187: 6167.
  • Djordjevic VB, Zvezdanovic L, Cosic V. 2008. [Oxidative stress in human diseases]. Srp Arh Celok Lek 136 ( Suppl 2): 158165.
  • Fogal B, McClaskey C, Yan S, Yan H, Rivkees SA. 2010. Diazoxide promotes oligodendrocyte precursor cell proliferation and myelination. PLoS One 5: e10906.
  • Frangogiannis NG, Smith CW, Entman ML. 2002. The inflammatory response in myocardial infarction. Cardiovasc Res 53: 3147.
  • Gmeiner M, Zimpfer D, Holfeld J, Seebacher G, Abraham D, Grimm M, Aharinejad S. 2011. Improvement of cardiac function in the failing rat heart after transfer of skeletal myoblasts engineered to overexpress placental growth factor. J Thorac Cardiovasc Surg 141: 12381245.
  • Guo C, Haider H, Wang C, Tan RS, Shim WS, Wong P, Sim EK. 2008. Myoblast transplantation for cardiac repair: from automyoblast to allomyoblast transplantation. Ann Thorac Surg 86: 18411848.
  • Hodgetts SI, Beilharz MW, Scalzo AA, Grounds MD. 2000. Why do cultured transplanted myoblasts die in vivo? DNA quantification shows enhanced survival of donor male myoblasts in host mice depleted of CD4+ and CD8+ cells or Nk1.1+ cells. Cell Transplant 9: 489502.
  • Huang Q, Bu S, Yu Y, Guo Z, Ghatnekar G, Bu M, Yang L, Lu B, Feng Z, Liu S, Wang F. 2007. Diazoxide prevents diabetes through inhibiting pancreatic beta-cells from apoptosis via Bcl-2/Bax rate and p38-beta mitogen-activated protein kinase. Endocrinology 148: 8191.
  • Huang L, Li B, Li W, Guo H, Zou F. 2009. ATP-sensitive potassium channels control glioma cells proliferation by regulating ERK activity. Carcinogenesis 30: 737744.
  • Kicinska A, Szewczyk A. 2003. Protective effects of the potassium channel opener-diazoxide against injury in neonatal rat ventricular myocytes. Gen Physiol Biophys 22: 383395.
  • Kitabayashi K, Siltanen A, Patila T, Mahar MA, Tikkanen I, Koponen J, Ono M, Sawa Y, Kankuri E, Harjula A. 2010. Bcl-2 expression enhances myoblast sheet transplantation therapy for acute myocardial infarction. Cell Transplant 19: 573588.
  • Li W, Ma N, Ong LL, Nesselmann C, Klopsch C, Ladilov Y, Furlani D, Piechaczek C, Moebius JM, Lutzow K, Lendlein A, Stamm C, Li RK, Steinhoff G. 2007. Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells 25: 21182127.
  • Maslov LN, Barzakh EI, Krylatov AV, Chernysheva GA, Krieg T, Solenkova NV, Lishmanov AY, Cybulnikov SY, Zhang Y. 2010. Opioid peptide deltorphin II simulates the cardioprotective effect of ischemic preconditioning: role of delta-opioid receptors, protein kinase C, and K(ATP) channels. Bull Exp Biol Med 149: 591593.
  • Minners J, Lacerda L, McCarthy J, Meiring JJ, Yellon DM, Sack MN. 2001. Ischemic and pharmacological preconditioning in Girardi cells and C2C12 myotubes induce mitochondrial uncoupling. Circ Res 89: 787792.
  • Minners J, Lacerda L, Yellon DM, Opie LH, McLeod CJ, Sack MN. 2007. Diazoxide-induced respiratory inhibition—a putative mitochondrial K(ATP) channel independent mechanism of pharmacological preconditioning. Mol Cell Biochem 294: 1118.
  • Niagara MI, Haider H, Jiang S, Ashraf M. 2007. Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart. Circ Res 100: 545555.
  • Oguz E, Ayik F, Ozturk P, Engin C, Nalbantgil S, Yagdi T, Ozbaran M. 2011. Long-term results of autologous stem cell transplantation in the treatment of patients with congestive heart failure. Transplant Proc 43: 931934.
  • Otani H. 2008. Ischemic preconditioning: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 10: 207247.
  • Pagani FD, DerSimonian H, Zawadzka A, Wetzel K, Edge AS, Jacoby DB, Dinsmore JH, Wright S, Aretz TH, Eisen HJ, Aaronson KD. 2003. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J Am Coll Cardiol 41: 879888.
  • Qu Z, Balkir L, van Deutekom JC, Robbins PD, Pruchnic R, Huard J. 1998. Development of approaches to improve cell survival in myoblast transfer therapy. J Cell Biol 142: 12571267.
  • Riederer I, Negroni E, Bigot A, Bencze M, Di Santo J, Aamiri A, Butler-Browne G, Mouly V. 2008. Heat shock treatment increases engraftment of transplanted human myoblasts into immunodeficient mice. Transplant Proc 40: 624630.
  • Robin E, Simerabet M, Hassoun SM, Adamczyk S, Tavernier B, Vallet B, Bordet R, Lebuffe G. 2010. Postconditioning in focal cerebral ischemia: role of the mitochondrial ATP-dependent potassium channel. Brain Res 1375: 137146.
  • Rosova I, Dao M, Capoccia B, Link D, Nolta JA. 2008. Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells 26: 21732182.
  • Salucci S, Battistelli M, Burattini S, Squillace C, Canonico B, Gobbi P, Papa S, Falcieri E. 2010. C2C12 myoblast sensitivity to different apoptotic chemical triggers. Micron 41: 966973.
  • Scorrano L, Korsmeyer SJ. 2003. Mechanisms of cytochrome c release by proapoptotic BCL-2 family members. Biochem Biophys Res Commun 304: 437444.
  • Siltanen A, Kitabayashi K, Patila T, Ono M, Tikkanen I, Sawa Y, Kankuri E, Harjula A. 2011. Bcl-2 improves myoblast sheet therapy in rat chronic heart failure. Tissue Eng Part A 17: 115125.
  • Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. 2002. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105: 9398.
  • Wang T, Zhang ZX, Xu YJ, Hu QH. 2007. 5-Hydroxydecanoate inhibits proliferation of hypoxic human pulmonary artery smooth muscle cells by blocking mitochondrial K(ATP) channels. Acta Pharmacol Sin 28: 15311540.
  • Zhao JP, Gao M, Ye YJ, Hu WH, Zhou ZG, Hu HL. 2009. [Regulation of rat airway smooth muscle cell proliferation by mitochondrial ATP-sensitive K(+) channel in asthmic rats.]. Sheng Li Xue Bao 61: 6571.
  • Zhu W, Chen J, Cong X, Hu S, Chen X. 2006. Hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells. Stem Cells 24: 416425.